Top 5 Income Stocks To Watch For 2014

Sam Champion, in leaving ABC’s “Good Morning America” to be managing editor and a show host at the Weather Channel, called his new gig a “once-in-a-lifetime opportunity.”

NEW YORK (CNNMoney) Last year, one popular morning television show replaced an anchor in the worst possible way: By forcing her out and leaving her humiliated on her last day. Now another morning show is replacing an anchor, and the contrast couldn’t be more stark.

ABC, which benefited enormously when NBC’s “Today” show dismissed Ann Curry, is amicably parting ways with Sam Champion.

Champion has been the weather anchor on “Good Morning America” for the past seven years. On Monday, he announced he is becoming managing editor of the Weather Channel and host of a forthcoming morning show.

Top 5 Income Stocks To Watch For 2014: MEDL Mobile Holdings Inc (MEDL)

MEDL Mobile Holdings, Inc. incorporated on May 22, 2008 is a developer, incubator, marketer and aggregator of mobile application software (Apps). The Company is engaged in the monetization of mobile application software through four revenue generating platforms: development of customized Apps for third parties to monetize their particular intellectual property, persona or brand, incubation of Apps in partnership with third parties and from a library of more than 75,000 original Apps concept submissions, sale of advertising and sponsorship opportunities directly to brands via mobile advertising networks and acquisition of Apps from other developers and use of a application programming interface ( API).

The Company develops Apps for customers that vary in size from small start-ups to large multinational corporations, in a range of industries including retailing, fast food, air travel, medical devices, higher education and fashion. As of December 31, 2011, revenu es its custom development accounted for approximately 93% of its total revenues. The Company prepares packages for sale in the Apple App Store and the Google Android Marketplace. This package includes app store copy, sample screen shots.

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap stocks Digital Caddies Inc (OTCMKTS: CADY), MEDL Mobile Holdings Inc (OTCMKTS: MEDL) and Yappn Corp (OTCMKTS: YPPN) offer different ways to potentially profit from Internet or mobile technology. However, all three small cap stocks have also been the subject of paid promotions or investor relations types of activities. So will investors actually profit from the efforts of these small caps to profit from the Internet or mobile technology? Here is a quick reality check:

Top 5 Income Stocks To Watch For 2014: Big 5 Sporting Goods Corporation(BGFV)

Big 5 Sporting Goods Corporation, together with its subsidiaries, operates as a sporting goods retailer in the western United States. The company offers athletic shoes, apparel, and accessories, as well as a selection of outdoor and athletic equipment for team sports, fitness, camping, hunting, fishing, tennis, golf, snowboarding, and roller sports. It also provides various private label merchandise, including shoes, apparel, binoculars, camping equipment, fishing supplies, and snow sport equipment. The company sells private label merchandise under its owned labels comprising Court Casuals, Golden Bear, Harsh, Pacifica, Rugged Exposure, and Triple Nickel; and licensed trademarks, including Avet, Body Glove, Fila, GoFit, Hi-Tec, Maui & Sons, Morrow, and Realm and The Realm. As of February 28, 2012, it operated 406 stores in 12 states under the Big 5 Sporting Goods name. The company was founded in 1955 and is headquartered in El Segundo, California.

Advisors’ Opinion:

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Big 5 Sporting Goods (Nasdaq: BGFV  ) , whose recent revenue and earnings are plotted below.

  • [By John Udovich]

    Yahoo! Finance recently noted once again how the hit reality show “Duck Dynasty” along with fears about Obama’s gun control policies have rural enthusiasts flocking to Cabela’s Inc (NYSE: CAB), but how does its performance compare with that of mid cap peer Dicks Sporting Goods Inc (NYSE: DKS) along with small caps Big 5 Sporting Goods Corporation (NASDAQ: BGFV) and Hibbett Sports, Inc (NASDAQ: HIBB)? After all, the same trends should be lifting all boats that sell outdoor related merchandise, guns or sporting goods (Note: Bass Pro, Inc, which is much closer to being a true peer of Cabela’s Inc as its also focused on the outdoors, is privately held) .  

Top 5 Income Stocks To Watch For 2014: California Republic Bancorp (CRPB)

California Republic Bank (the Bank) provides an integrated banking solution to its customers. The Company provides a range of products and services, such as deposit and cash management, loans and private banking. The deposit and cash management include real time, online Internet banking, business analyzed checking, IOLTA accounts, NOW Accounts, nationwide network of cash vault centers, remote Deposit capture, fully automated domestic and international wire transfers, lockbox processing services, free worldwide automated teller machines (ATM) and debit cards, credit cards and purchase card services, customized merchant banking services, fraud prevention products including positive-pay, secure online applications, including token device with internal control access, and contractor Retention Escrow Accounts.

The loan services include unsecured lines of credit, secured revolving lines of credit, working capital loans, equipment financing, asset based credit lines, commercial owner occupied real estate loans, investor real estate loans and construction loans. Its private banking includes full array of private banking loans and lines of credit, Bill pay services, and stock secured credit lines and loans.

The Bank provides banking services to commercial entities, their owners, high net-worth individuals and active investors. It provides commercial banking, lending services, deposit services, contractor retention escrow accounts, cash management, remote deposit capture, private banking, online banking and auto finance.

The commercial banking includes online banking services, cash management products and services, remote deposit capture, contractor retention escrow accounts, domestic and international wire transfers, checking accounts, NOW accounts, money market accounts (MMA), savings accounts, certificates of deposit (CDs), corporate credit card, analyzed accounts and IOLTA accounts. The Bank offer lines of credit to provide working capital for day-to-day operations, term loan! s for equipment, and commercial real estate loans for facilities and for investment portfolio.

The cash management includes Account Analysis, Master Agreement Accounts, Account Reconciliation, Remote Deposit Capture (RDC), Online Cash Management, Automated Clearing House (ACH) Services, Bill Pay, Lockbox Services, Positive Pay, Zero Balancing Accounts, Merchant Card, Reverse Wires, Statements on CD Rom, Corporate Credit Card, Courier Service and Bank by Mail.

Advisors’ Opinion:

  • [By CRWE]

    Today, CRPB remains (0.00%) +0.000 at $19.00 thus far (ref. google finance Delayed:   11:35AM EDT July 29, 2013).

    California Republic Bancorp previously reported its results for the second-quarter 2013, reporting quarterly net income of $2.8 million, record net interest margin of 6.41%, record assets of $737.1 million and record deposits of $669.7 million.

    CEO Jon Wilcox stated, “In the second-quarter we not only experienced strong deposit and loan growth, but also continued to invest in our people and infrastructure both in California as well as nationally, while increasing our bottom line and maintaining solid credit quality.”

Top 5 Income Stocks To Watch For 2014: Pain Therapeutics Inc (PTIE)

Pain Therapeutics, Inc., incorporated in May 1998, is a biopharmaceutical company that develops drugs. The Company has four drug candidates in clinical programs, including REMOXY, abuse-resistant hydromorphone, abuse-resistant hydrocodone and a radio-labeled monoclonal antibody to treat metastatic melanoma. It is also working on a new treatment for patients with hemophilia. The Company’s lead drug candidate is REMOXY, which is a painkiller. It has collaboration agreement with King Pharmaceuticals, Inc (King) develops and commercializes REMOXY and other opioid painkillers. The Company and King jointly managed a Phase III clinical program and New Drug Application (NDA) submission for REMOXY. It is also developing a pipeline of drug candidates in the area of oncology and hematology. It owns all commercial rights to its pipeline of drug candidates in oncology and hematology. As of December 31, 2010, the Company leased approximately 30,700 square feet of space in San Mateo, California and all of its operations are located in San Mateo.

REMOXY

REMOXY is a controlled-release oral capsule form of oxycodone in a highly viscous liquid formulation matrix that includes excipients. It is formulated to help address issues of abuse and misuse of time-release oxycodone tablets. REMOXY’s capsule dosage form provides therapeutic drug levels of oxycodone on a twice-daily dosing schedule, while resisting the rapid increases in plasma levels of oxycodone associated with common methods of abuse and misuse. Its formulation also resists delivery by unapproved routes of administration, such as injection, snorting or inhalation.

Metastatic Melanoma

The Company is developing a drug candidate called PTI-188 to treat metastatic melanoma, a form of skin cancer. PTI-188 is a monoclonal antibody linked to a radioisotope, intended to deliver doses of radiation lethal to melanoma tumors without harming normal tissue. I n March 2010, the Company announced data from two open-label! , dose-escalating Phase I studies conducted in Israel to assess the safety, pharmacokinetics, dosimetry and anti-tumor activity of PTI-188. During the year ended December 31, 2010, the second study was completed. The technology used in this program was developed at the Albert Einstein College of Medicine (AECOM). It had licensed worldwide commercial rights to this technology from AECOM.

Hemophilia

The Company has a gene transfer program, initially developed at Stanford University, focused at correcting a genetic disorder in which patients are unable to stop bleeding. During 2010, it conducted a variety of pre-clinical studies with this technology. The Company has licensed worldwide commercial rights to the technology used in this program from Poetic Genetics, LLC (Poetic).

Other product candidates

The Company’s alliance with King includes development of three other abuse-resistant opioid product candidates: hydromorphone , hydrocodone and oxymorphone. Its abuse-resistant formulations of hydromorphone and hydrocodone have completed Phase I clinical trials. In January 2011, the Company announced that the Food and Drug Administration (FDA) had accepted its investigational IND, for abuse-resistant oxymorphone.

The Company competes with Roxane Laboratories, Purdue Pharma, King Pharmaceuticals, Inc., Abbott Laboratories, Cephalon, Endo Pharmaceuticals, Teva Pharmaceuticals, Elkins-Sinn, Watson Laboratories, Ortho-McNeil Pharmaceutical and Forest Pharmaceuticals.

Advisors’ Opinion:

  • [By Sean Williams]

    However, all isn’t well when it comes to the future of abuse-resistant painkiller Remoxy, which was developed by Pain Therapeutics (NASDAQ: PTIE  ) , using Durect’s special technology-based gel capsule to prevent abuse, and is licensed by Pfizer (NYSE: PFE  ) . Remoxy has been rejected twice by the FDA — the most recent coming in mid-2011 — and Pfizer commented this morning that if it were to seek reapproval for the drug it wouldn’t be for at least two more years. Given Pfizer’s extensive product pipeline, losing Remoxy wouldn’t be a big deal. For micro-cap clinical-stage companies like Pain Therapeutics and Durect, it’d be a gigantic blow. Fittingly, Pain Therapeutics and Durect shares imploded by 50% and 34%, respectively, on Friday.

  • [By Jessica Alling]

    Elsewhere, Pfizer is evaluating its continued partnership on an experimental oxycodone capsule, Remoxy. The drug is an extended-release formula that is targeted at reducing abuse of the painkiller. After years of setbacks and postponements for FDA approval, Pfizer is weighing its options. Its partners for the drug, Pain Therapeutics (NASDAQ: PTIE  ) and Durect, have both fallen heavily due to the news, with Pain Therapeutics falling more than 50% — its largest decline ever.

Top 5 Income Stocks To Watch For 2014: Main Street Capital Corp (MAIN)

Main Street Capital Corporation (MSCC) is a principal investment firm primarily focused on providing customized debt and equity financing to lower middle market (LMM) companies, which it generally define as companies with annual revenues between $10 million and $100 million that operate in diverse industries. Main Street’s LMM portfolio investments principally consist of secured debt, equity warrants and direct equity investments in privately held LMM companies. Main Street’s privately placed portfolio investments consist of primarily debt investments in middle market businesses that are generally larger in size than the portfolio companies within the LMM portfolio. Its LMM portfolio investments range in size from $5 million to $25 million. As of December 31, 2011, it had debt and equity investments in 54 LMM portfolio companies. On February 29, 2012, MSCC completed the exit of its debt investment and a portion of its equity investments in Drilling Info, Inc., (Drilling In fo). Effective September 5, 2013, Main Street Capital Corp acquired TBT Holding Co Inc, a manufacturer of dump trailers, from Harbert Management Corp’s Harbert Private Equity Fund II LLC subsidiary.

On January 5, 2012, Main Street fully exited its debt and equity investments in Currie Acquisitions, LLC (Currie). On February 17, 2012, MSCC acquired a total of approximately 8.5% of the total dollar value of the MSC II limited partnership interests not owned by MSCC. The Company has approximately 75% of its total LMM portfolio investments at cost were in the form of debt investments as of December 31, 2011. At December 31, 2011, it had equity ownership in approximately 94% of its LMM portfolio companies and the average fully diluted equity ownership in those portfolio companies was approximately 34%. Its portfolio investments are generally made through MSCC and the Funds.

Debt Investments

The Company’s LMM debt investments have terms o f three to seven years, with limited required amortization p! rior to maturity, and provide for monthly or quarterly payment of interest at fixed interest rates generally between 12% and 14% per annum, payable in cash. The Company also provides floating interest rates for a portion of a single tranche debt security. In addition, certain LMM debt investments may have a form of interest that is not paid but is accrued and added to the loan balance and paid at maturity. As of December 31, 2011, 93% of its LMM debt investments at cost were secured by first priority liens on the assets of LMM portfolio companies. In addition to seeking a senior lien position in the capital structure of its LMM portfolio companies, it seeks to limit the downside of its LMM investments by negotiating covenants that are designed to protect its LMM investments while affording its portfolio companies as much flexibility in managing their businesses as is reasonable.

Warrants

In connection with its LMM debt investments, the Company has received equity warrants to establish or increase its equity interest in the LMM portfolio company. Warrants it receives in connection with a LMM debt investment typically require only a nominal cost to exercise, and thus, as a LMM portfolio company appreciates in value, it may achieve additional investment return from this equity interest. The Company structures the warrants to provide provisions protecting the rights as a minority-interest holder, as well as secured or unsecured put rights, or rights to sell such securities back to the LMM portfolio company, upon the occurrence of specified events.

Direct Equity Investments

The Company usually makes its direct equity investments in connection with debt investments. In addition, the Company may have both equity warrants and direct equity positions in some of its LMM portfolio companies. The Company makes its direct equity investments in connection with debt investments. In addition, it may have bot h equity warrants and direct equity positions in some of its! LMM port! folio companies. It seeks to maintain fully diluted equity positions in its LMM portfolio companies of 5% to 50%, and may have controlling equity interests in some instances.

Advisors’ Opinion:

  • [By Grass Hopper]

    Examples of the first class of publicly ‐traded private equity firms include Kohlberg Kravis Roberts & Co. L.P. (KKR), The Blackstone Group L.P. (BX), and Oaktree Capital Group, LLC (OAK). Examples of the second class are Wendel SA (MF FP), Exor SpA (EXO IM) and, to some extent, Reinet Investments SCA (REI SJ). Examples of the third class are American Capital, Ltd. (ACAS), Main Street Capital, Gladstone Capital Corp. (MAIN), and Prospect Capital Corp. (PSEC).

  • [By GURUFOCUS]

    Main Street Capital Corporation (MAIN) is a business development company specializing in long- term equity, equity related, and debt investments in small and lower middle market companies. Yield: 6.3%

  • [By Marc Bastow]

    Customized debt and equity financing company Main Street Capital (MAIN) raised its quarterly dividend 10% to 16.5 cents per share for January, February, and March. The payable, record and ex-dividend dates are as follows: payable on Jan. 15 to shareholders of record as of Dec. 30; payable on Feb. 14 to shareholders of record as of Jan. 21; payable on Mar. 14 to shareholders of record as of Feb. 20.
    MAIN Dividend Yield: 6.36%